Innovation & intellectual property · 29/06/2022

USPTO Extends Cancer Immunotherapy Pilot Program Until September 30, 2022, Seeks Public Feedback

The USPTO is extending the Cancer Immunotherapy Pilot Program, which supports the White House's National Cancer Moonshot initiative, until September 30, 2022, and is seeking public comments on potential program expansions and modifications.